1 Brilliant AI Stock That You Should Buy Hand Over Fist in 2026

Broadcom has posted rapid expansion driven by AI chips and acquisitions: revenue rose from $23.9B in fiscal 2020 to $63.9B in fiscal 2025 (22% CAGR) while adjusted EBITDA grew from $13.6B to $43.0B (26% CAGR). AI chip sales jumped 65% to $20B in fiscal 2025, comprising 31% of revenue, and management targets $60B–$90B in annualized AI chip revenue by end of fiscal 2027 concentrated with three hyperscalers. Analysts project FY2025–FY2028 revenue and adjusted EBITDA CAGRs of ~38% and 36%, and Broadcom trades at an enterprise value of $1.65T, roughly 26x this year’s adjusted EBITDA, reflecting a growth-at-a-reasonable-valuation thesis bolstered by strategic acquisitions such as VMware.

Analysis

Market structure: Broadcom (AVGO) is shifting value to “picks-and-shovels” suppliers as hyperscalers outsource custom AI accelerators, benefiting Broadcom, optical/networking suppliers, and infrastructure software (VMware) licensors while pressuring general-purpose GPU pricing power at Nvidia (NVDA). The concentration risk is high: three hyperscalers are expected to drive the jump from $20B AI revenue (FY25) to a $60–90B FY27 target, implying order concentration and lumpy demand cycles over 12–36 months.

Risk assessment: Key tail risks include a hyperscaler pivot back to Nvidia or in‑house silicon (20–30% downside to AVGO AI revenue if one large customer reduces orders), antitrust scrutiny on M&A/integration of VMware, and supply-chain bottlenecks for custom accelerators. Short-term (days/weeks) price moves will react to quarterly guidance; medium-term (6–18 months) risk is execution on FY27 AI revenue targets; long-term (2–5 years) risks center on customer concentration and margin sustainability.

Trade implications: Favor direct AVGO exposure as a defensive AI-picks play but size positions conservatively (2–4% of portfolio) and use defined-risk options to leverage. Relative-value: expect AVGO to re-rate vs NVDA if hyperscalers sign multi-year exclusives; volatility spikes around earnings/guidance (±15–30%) create attractive call spread and collar opportunities for 9–18 month horizons.

Contrarian angles: The market may underprice customer concentration and integration drag — a single hyperscaler cut could shave >20% off FY27 AI revenue expectations. Conversely, consensus may under-appreciate recurring software cash flows from VMware that de-risk cyclicality; mispricings exist if AVGO delivers 10–15% beats to AI revenue guidance.

Key Decisions for Investors

• Establish a 2–4% long position in AVGO (equity) with a 12–18 month horizon; trim into strength at +20–30% or cut if FY27 AI revenue guidance midpoint is below $54B (10% below $60B target) or adjusted EBITDA CAGR guidance falls below 30%.
• Implement a defined-risk options sleeve: buy 9–15 month AVGO call spreads ~20–30% OTM (buy lower strike, sell higher strike) sized to equal a 2% equity exposure to capture upside to FY27 re-rating while capping premium loss.
• Relative-value pair: run dollar-neutral long AVGO / short NVDA at 2:1 notional (AVGO overweight) for 6–12 months to capture picks-and-shovels re-rating; tighten if NVDA launches aggressive price cuts or AVGO signs multi-year exclusivity covering >70% of its FY27 AI guidance.
• Hedge customer concentration: buy 6–9 month AVGO put protection (10% OTM) equal to ~25% of the AVGO position if Broadcom fails to disclose multi-year hyperscaler contracts within the next two earnings cycles (60 days x2).